In conclusion, we show that TP53 germline mutations occur at a comparable frequency with BRCA1 and BRCA2 germline mutations among Asian early-onset breast cancer patients, and occur predominantly, but not exclusively, among families which have a family history of LFS-linked cancers. This evidence concerns the gene TP53 and cancer.